Dyslipidemia in type 2 diabetes mellitus

被引：0
|
作者：
Arshag D Mooradian
机构：
[1] University of Florida College of Medicine,AD Mooradian is a Professor and Chair of the Department of Medicine
[2] Jacksonville,undefined
[3] FL,undefined
[4] USA.,undefined
来源：
Nature Reviews Endocrinology | 2009年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Diabetic dyslipidemia, characterized by low HDL cholesterol level and high levels of triglyceride and small dense, LDL cholesterol, greatly increases the risk of cardiovascular disease. Given the complexity of the dyslipidemic profile, multiple agents are often required to achieve therapeutic goals. This Review discusses the use of various pharmacological agents as well as lifestyle changes for the treatment of dyslipidemia in diabetes mellitus.
引用
收藏
页码：150 / 159
页数：9
相关论文
共 50 条
  • [31] THE INFLUENCE OF DYSLIPIDEMIA ON THE PERIODONTAL STATUS IN TYPE 2 DIABETES MELLITUS PATIENTS
    Surdu, Amelia
    Martu, Ioana
    Ursarescu, Irina
    Scutariu, Monica
    Martu, Silvia
    Balan, Adriana
    [J]. ROMANIAN JOURNAL OF ORAL REHABILITATION, 2014, 6 (04): : 38 - 44
  • [32] Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus
    Tangvarasittichai, Surapon
    [J]. WORLD JOURNAL OF DIABETES, 2015, 6 (03): : 456 - 480
  • [33] The Characteristics of Dyslipidemia and Hypertension in Elderly Patients with Type 2 Diabetes Mellitus
    Sarac, Fulden
    Savas, Sumru E.
    Sarac, Sefa
    Akcicek, Fehmi
    [J]. DIABETES, 2015, 64 : A419 - A419
  • [34] Dyslipidemia and its associated factors in patients with type 2 diabetes mellitus
    Bawah, Ahmed Tijani
    Darko, Richard
    Abaka-Yawson, Albert
    Seini, Mohammed Mustapha
    Kinanyok, Silas
    Adusei, Samuel
    [J]. JOURNAL OF PUBLIC HEALTH-HEIDELBERG, 2021, 29 (04): : 985 - 991
  • [35] Evaluation of the Effects of Dyslipidemia on Hearing in Patients with Type 2 Diabetes Mellitus
    Sriram Madhan
    Rakesh Bambore Suryanarayan Rao
    Ashok Parameshwarappa
    Bharathi Murundi Basavaraj
    Prakash Bhadravathi Ganesh
    Sandeep Shetty
    Thanzeem Unisa
    Kavya Sivapuram
    [J]. Indian Journal of Otolaryngology and Head & Neck Surgery, 2023, 75 : 541 - 547
  • [36] Pathophysiology of dyslipidemia in patients with metabolic syndrome or type 2 diabetes mellitus
    Verges, Bruno
    [J]. NUTRITION CLINIQUE ET METABOLISME, 2007, 21 (01): : 9 - 16
  • [37] Apolipoprotein B and its correlation with dyslipidemia in Type 2 Diabetes Mellitus
    Makaju, H. S.
    Sharma, V. K.
    Yadav, B. K.
    Tuladhar, E. T.
    Bhandari, R.
    Bhattarai, A.
    Raut, M.
    Dubey, R. K.
    Niraula, A.
    Sapkota, A.
    Neupane, A.
    Ramtel, R.
    [J]. CLINICA CHIMICA ACTA, 2024, 558
  • [38] Antihyperglycemic Action of Saroglitazar in Patients with Type 2 Diabetes Mellitus and Dyslipidemia
    Chhaya, Gaurav Hemendra
    Patel, Nitesh C.
    [J]. DIABETES, 2017, 66 : A338 - A338
  • [39] Dyslipidemia in Young Patients With Type 1 Diabetes Mellitus
    Homma, Thais K.
    Noronha, Renata
    Endo, Camila
    Saruhashi, Tatiana
    Mori, Ana Paula
    Kochi, Cristiane
    Calliari, Luis Eduardo
    [J]. DIABETES, 2013, 62 : A682 - A682
  • [40] Dyslipidemia in young patients with type 1 diabetes mellitus
    Homma, Thais Kataoka
    Endo, Camila Matsuura
    Saruhashi, Tatiana
    Ivata Mori, Ana Paula
    de Noronha, Renata Maria
    Monte, Osmar
    Procopio Calliari, Luis Eduardo
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2015, 59 (03): : 215 - 219
12345